← Eichor
Study identifier: NCT07207577 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Evaluation of Physiological and Psychological Factors Involved in Exercise Intolerance in Patients With β-TTD

Condition: Beta Thalassemia Transfusion Dependent  ·  Sponsor: Centre Hospitalier Metropole Savoie

PhaseNA
Planned participants36
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

About this study

The goal of this clinical trial is to compare physical ability of patients with transfusion-dependent β-thalassemia to control subjects. The main question it aims to answer is: is there a difference in power output at first lactate threshold between patients with transfusion-dependent β-thalassemia and control subjects during maximal incremental exercise test. Participants will have to realise differents exams including measurement of body compposition, maximal incremental exercise test, vertical jump, vasoreactivity test, blood sampling, quality of life questionnaires and neuromuscular assessments.

This description comes directly from the study's public registry record.

Talk to the study team

Charlene DUPRE  ·  +33479965910  ·  charlene.dupre@ch-metropole-savoie.fr

Leo BLERVAQUE  ·  +33479965910  ·  leo.blervaque@ch-metropole-savoie.fr

Always discuss trial participation with your own doctor first.

Locations (1)

CH Métropole SavoieChambéry, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07207577